In this section
@article{Smitten:2019:10.1039/c9sc04710g,
author = {Smitten, KL and Fairbanks, SD and Robertson, CC and Bernardino, de la Serna J and Foster, SJ and Thomas, JA},
doi = {10.1039/c9sc04710g},
journal = {Chemical Science},
pages = {70--79},
title = {Ruthenium based antimicrobial theranostics – using nanoscopy to identify therapeutic targets and resistance mechanisms in Staphylococcus aureus},
url = {http://dx.doi.org/10.1039/c9sc04710g},
volume = {11},
year = {2019}
}
TY - JOUR
AB - In previous studies we reported that specific dinuclear RuII complexes are particularly active against pathogenic Gram-negative bacteria and, unusually for this class of compounds, appeared to display lowered activity against Gram-positive bacteria. With the aim of identifying resistance mechanisms specific to Gram-positive bacteria, the uptake and antimicrobial activity of the lead complex against Staphylococcus aureus SH1000 and other isolates, including MRSA was investigated. This revealed differential, strain specific, sensitivity to the complex. Exploiting the inherent luminescent properties of the RuII complex, super-resolution STED nanoscopy was used to image its initial interaction with S. aureus and confirm its cellular internalization. Membrane damage assays and transmission electron microscopy confirm that the complex disrupts the bacterial membrane structure before internalization, which ultimately results in a small amount of DNA damage. A known resistance mechanism against cationic antimicrobials in Gram-positive bacteria involves increased expression of the mprF gene as this results in an accumulation of positively charged lysyl-phosphatidylglycerol on the outer leaflet of the cytoplasmic membrane that electrostatically repel cationic species. Consistent with this model, it was found that an mprF deficient strain was particularly susceptible to treatment with the lead complex. More detailed co-staining studies also revealed that the complex was more active in S. aureus strains missing, or with altered, wall teichoic acids.
AU - Smitten,KL
AU - Fairbanks,SD
AU - Robertson,CC
AU - Bernardino,de la Serna J
AU - Foster,SJ
AU - Thomas,JA
DO - 10.1039/c9sc04710g
EP - 79
PY - 2019///
SN - 2041-6520
SP - 70
TI - Ruthenium based antimicrobial theranostics – using nanoscopy to identify therapeutic targets and resistance mechanisms in Staphylococcus aureus
T2 - Chemical Science
UR - http://dx.doi.org/10.1039/c9sc04710g
UR - https://pubs.rsc.org/en/content/articlelanding/2020/SC/C9SC04710G#!divAbstract
UR - http://hdl.handle.net/10044/1/75133
VL - 11
ER -